帕利维祖马是儿童喘发展的保护因素吗? 通过分析进行系统审查
Mariana Bueno Manini1, Natali Caroline da Silva1, Rafaela Agra de Castro2
1Child and Adolescent Health Postgraduate Program, State University of Campinas, Campinas, São Paulo, Brazil.
Pediatric pulmonology
|August 22, 2025
概括
在没有心脏病的早产婴儿中,Palivizumab的预防不能预防喘. 这种药物主要减少严重的呼吸道同胞病毒 (RSV) 感染,而不是儿童喘的发展.
科学领域:
- 儿童肺病学
- 新生儿学
- 临床免疫学
背景情况:
- 过早出生的婴儿面临慢性呼吸系统疾病和RSV等严重感染的风险.
- 已知帕利维祖马布可以减轻高风险婴儿的RSV严重程度,但其对喘发展的影响尚未得到充分证实.
研究的目的:
- 系统地审查和分析现有文献.
- 确定帕利维祖马布的预防能否保护早产婴儿 (没有先天性心脏病) 免受喘的影响.
主要方法:
- 14项研究的系统审查和元分析.
- 包括1,364,238名儿童的数据,其中9232人接受了帕利维祖马布治疗.
- 进行了子组和敏感性分析以评估强度和特定群体.
主要成果:
- 接受帕利维祖马布和对照组之间喘发展没有显著差异 (OR 0.84, p=0. 1968).
- 对亚组的分析也没有显示出明显的喘风险降低.
- 接受帕利维祖马布治疗的婴儿的诊断年龄较小,但怀孕年龄的差异并不显著.
结论:
- 在没有先天性心脏病的早产婴儿中,帕利维祖马布预防不降低喘风险.
- 帕利维祖马布的确定的益处在于预防严重的RSV感染,而不是预防喘发作.
相关概念视频
Asthma: Pathogenesis and Management
581
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
581
Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
453
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
453
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Antiasthma Drugs: Leukotriene Modifiers
463
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
463
Asthma-III: Symptoms and Complications
2.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.6K


